MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Understand the impact of genetic testing in diagnosing periodic paralysis. Discover how identifying mutations can lead to targeted treatments and better patient outcomes.
Uncover how genetic testing aids in diagnosing peripheral precocious puberty, guiding treatment, and offering crucial genetic counseling for affected families.
Explore the role of genetic testing in diagnosing Porphyria Cutanea Tarda, understand UROD gene mutations, and learn how personalized treatments can improve life quality.
Genetic testing revolutionizes primary adrenocortical insufficiency diagnosis and treatment, offering early detection, personalized care, and family planning insights.
Explore how genetic testing aids in early detection and personalized treatment of primary peritoneal carcinoma, enhancing patient outcomes and family planning.
Genetic testing transforms PFIC diagnosis, unveiling mutations for precise care and enhancing treatment through early intervention and personalized strategies.
Explore how genetic testing aids in diagnosing pulmonary arterial hypertension. Early detection and personalized treatments enhance management and family planning strategies.
Explore how genetic testing unravels alpha-sarcoglycan defects, offering insights into diagnosis, family planning, and cutting-edge research advancements in LGMDs.